Search
Trolamine
go.drugbank.com/drugs/DB13747ApprovedInvestigationalIt is commonly used as a pH adjuster and surfactant in industrial and cosmetic products such as skin and hair conditioning products. … Trolamine contains small amounts of diethanolamine and ethanolamine and may also act as an antioxidant against the auto-oxidation of animal and vegetable fats [A27174].
Mixtures: RUNYI MIAOJIE Hand sanitizer, RUNYI MIAOJIE Hand sanitizerCategories: Preparations for Treatment of Wounds and UlcersDimethicone 410
go.drugbank.com/drugs/DB14005Approved[L1769] It is currently recognized by the FDA as a skin protectant OTC ingredient for human use in a concentration of 1-30%. … Dimethicone is a silicone-based polymer used as a moisturizer in different skin OTC products.[A32462] It is formed by repeated polymeric units of -(CH3)2SiO- with a terminal trimethyl siloxy unit.
Strontium ranelate
go.drugbank.com/drugs/DB09267ApprovedWithdrawnThis agent presents an atypical mechanism of action in which it increases deposition of new bone by osteoblasts and, simultaneously, reduces the resorption of bone by osteoclasts. … Available for prescription use for a time in some parts of the world as Protelos (strontium ranelate) 2 g granules for oral suspension by Servier, it was ultimately discontinued in 2016-2017 owing to an
Mixtures: STRODAY D3 2G/800 IU SAŞE , 28 SAŞE, FULLBONE D3 2 G/800 IU EFERVESAN TABLET, 30 ADETCategories: strontium ranelate and colecalciferol, Drugs Affecting Bone Structure and MineralizationLeucine
go.drugbank.com/drugs/DB00149ApprovedInvestigationalNutraceuticalAn essential branched-chain amino acid important for hemoglobin formation.
Mixtures: Aminosyn II and Dextrose, Aminosyn II and DextroseCategories: Amino Acids, Peptides, and ProteinsDurvalumab
go.drugbank.com/drugs/DB11714ApprovedInvestigational[A192789,L12627] On March 27, 2020, durvalumab was approved by the FDA for use in combination with [etoposide] and either [carboplatin] or [cisplatin] as first-line treatment of patients with extensive-stage … [L12621] In September 2018, durvalumab was approved by the EMA for the treatment of adult patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), only if PD-L1 is expressed in
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsDrug Poisoning
go.drugbank.com/conditions/DBCOND0063975Drugs: Sodium phosphate, monobasicSynonyms: Drug and medicament poisoning NOS (disorder), Drug-Related Side Effects and Adverse ReactionsMenstrual Flow Excessive
go.drugbank.com/conditions/DBCOND0092700Drugs: Dienogest · Elagolix · Estradiol · Estradiol valerate · Ethynodiol diacetate · Levonorgestrel +8 moreSynonyms: Excessive and frequent menstruation, Excessive and frequent menstruation (finding)Suppurative Otitis Media
go.drugbank.com/conditions/DBCOND0107024Drugs: CiprofloxacinSynonyms: Suppurative and unspecified otitis media, SOM - Suppurative and unspecified otitis mediaElasomeran
go.drugbank.com/drugs/DB15654ApprovedInvestigationalFor the 2024-2025 season, an updated formulation was approved for use in Canada and the US to target the Omicron KP.2 subvariant.[L51404,L40074] … [L39160, L39277] A similar booster dose is also available in the US for patients 18 years of age and older.